title: Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study.
abstract: Community-acquired lower respiratory tract infections (LRTI) and pneumonia (CAP) are common causes of morbidity and mortality among those aged ≥65 years; a growing population in many countries. Detailed incidence estimates for these infections among older adults in the United Kingdom (UK) are lacking. We used electronic general practice records from the Clinical Practice Research Data link, linked to Hospital Episode Statistics inpatient data, to estimate incidence of community-acquired LRTI and CAP among UK older adults between April 1997-March 2011, by age, sex, region and deprivation quintile. Levels of antibiotic prescribing were also assessed. LRTI incidence increased with fluctuations over time, was higher in men than women aged ≥70 and increased with age from 92.21 episodes/1000 person-years (65-69 years) to 187.91/1000 (85-89 years). CAP incidence increased more markedly with age, from 2.81 to 21.81 episodes/1000 person-years respectively, and was higher among men. For both infection groups, increases over time were attenuated after age-standardisation, indicating that these rises were largely due to population aging. Rates among those in the most deprived quintile were around 70% higher than the least deprived and were generally higher in the North of England. GP antibiotic prescribing rates were high for LRTI but lower for CAP (mostly due to immediate hospitalisation). This is the first study to provide long-term detailed incidence estimates of community-acquired LRTI and CAP in UK older individuals, taking person-time at risk into account. The summary incidence commonly presented for the ≥65 age group considerably underestimates LRTI/CAP rates, particularly among older individuals within this group. Our methodology and findings are likely to be highly relevant to health planners and researchers in other countries with aging populations.
authors.affiliation: Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom.
authors.forename: Elizabeth R C
authors.initials: ER
authors.lastname: Millett
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Quint
authors.forename: Liam
authors.initials: L
authors.lastname: Smeeth
authors.forename: Rhian M
authors.initials: RM
authors.lastname: Daniel
authors.forename: Sara L
authors.initials: SL
authors.lastname: Thomas
mesh_terms: D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology*; D011307:Drug Prescriptions / Q000706:statistics & numerical data; D005260:Female; D005843:Geography; D006801:Humans; D015994:Incidence; D008297:Male; D011014:Pneumonia / Q000188:drug therapy / Q000453:epidemiology*; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000453:epidemiology*; D017678:Sex Distribution; D012923:Social Class; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Fam Pract. 2006 Jun;23(3):291-4
references.pmid: 16464869
references.citation: J Public Health (Oxf). 2006 Sep;28(3):242-7
references.pmid: 16820432
references.citation: Br J Gen Pract. 2005 Aug;55(517):603-8
references.pmid: 16105368
references.citation: Clin Microbiol Infect. 2011 Nov;17 Suppl 6:1-24
references.pmid: 21951384
references.citation: Epidemiol Infect. 2009 May;137(5):709-16
references.pmid: 18840320
references.citation: J Clin Pharm Ther. 2006 Oct;31(5):461-7
references.pmid: 16958824
references.citation: Thorax. 2009 Dec;64(12):1062-9
references.pmid: 19454409
references.citation: Health Stat Q. 2010 Spring;(45):100-27
references.pmid: 20383167
references.citation: Eur Respir J. 2000 Apr;15(4):757-63
references.pmid: 10780770
references.citation: Thorax. 1999 Oct;54(10):925-8
references.pmid: 10491457
references.citation: J Public Health (Oxf). 2004 Sep;26(3):268-74
references.pmid: 15454595
references.citation: Eur Respir J. 2007 May;29(5):969-75
references.pmid: 17215313
references.citation: J Infect. 2006 Sep;53(3):166-74
references.pmid: 16375972
references.citation: J Infect. 2007 Sep;55(3):233-9
references.pmid: 17599417
references.citation: Arch Intern Med. 2003 Feb 10;163(3):317-23
references.pmid: 12578512
references.citation: Vaccine. 2003 Mar 7;21(11-12):1137-48
references.pmid: 12559791
references.citation: Thorax. 2006 Mar;61(3):250-8
references.pmid: 16517585
references.citation: Am J Epidemiol. 1993 May 1;137(9):977-88
references.pmid: 8317455
references.citation: Thorax. 2001 Dec;56 Suppl 4:IV1-64
references.pmid: 11713364
references.citation: Thorax. 2001 Feb;56(2):109-14
references.pmid: 11209098
references.citation: J Public Health (Oxf). 2009 Dec;31(4):512-20
references.pmid: 19734168
references.citation: Thorax. 2003 May;58(5):377-82
references.pmid: 12728155
references.citation: Thorax. 2008 Sep;63(9):817-22
references.pmid: 18388206
references.citation: BMC Public Health. 2008 Jun 27;8:222
references.pmid: 18582392
references.citation: BMJ. 2007 Nov 10;335(7627):982
references.pmid: 17947744
references.citation: Chest. 2009 May;135(5):1163-1172
references.pmid: 19420194
references.citation: Pharmacoepidemiol Drug Saf. 2005 Jul;14(7):443-51
references.pmid: 15898131
references.citation: Int J Tuberc Lung Dis. 2004 May;8(5):528-36
references.pmid: 15137527